1
This study evaluated the efficacy and safety of AP over 4 weeks in subjects with symptomatic GERD.
2
Conclusions: Once-daily therapy with 10 or 20 mg of rabeprazole effectively prevents pathological and symptomatic GERD relapse.
3
The base-case patient was a 45-year-old man with symptomatic GERD taking 20 mg of omeprazole twice daily.
4
Methods: A total of 207 symptomatic GERD patients, which were confirmed by endoscopy from July 2008 till January 2009, were enrolled.